Welcome to our dedicated page for Safety Shot SEC filings (Ticker: SHOT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings for Safety Shot, Inc., now operating under the name Bonk, Inc., provide detailed insight into the company’s transformation from a CBD-focused consumer products issuer into a business centered on digital assets, the BONK ecosystem, and beverage brands. On this page, investors can review the company’s Forms 10-K and 10-Q, along with current reports on Form 8-K and related proxy materials, to understand how its strategy and capital structure have evolved.
Recent filings include an NT 10-Q (Form 12b-25) in which Bonk, Inc. explains a delay in filing its quarterly report for the period ended September 30, 2025 due to the need for additional time to finalize financial statements and complete the review by its independent public accounting firm. Multiple Form 8-K reports detail material events such as the corporate name change to Bonk, Inc., the trading symbol change to BNKK on the Nasdaq Capital Market, amendments to the certificate of incorporation to increase authorized common shares, and amendments to the Series C Convertible Preferred Stock designation.
Other 8-K filings describe a Series C Preferred Stock financing and a registered direct offering with a concurrent private placement in which BONK tokens serve as consideration, as well as Nasdaq Listing Qualifications correspondence regarding notification, shareholder approval, and voting rights rules. These documents outline how the company addressed listing rule issues and regained compliance. The definitive proxy statement on Schedule 14A for a special meeting of stockholders provides further detail on proposals to increase authorized shares and approve potential share issuances tied to its financing and revenue sharing agreements.
Through Stock Titan, users can access these filings as they are posted to EDGAR and use AI-powered summaries to interpret complex sections, such as preferred stock terms, share authorization changes, revenue sharing agreements, and treasury management disclosures. The filings page also surfaces insider and governance-related disclosures where applicable, giving investors a structured view of how the company’s BONK-focused strategy and beverage division are reflected in its formal reporting.
Safety Shot, Inc. appointed Markita Russell as Chief Financial Officer under a new employment agreement dated October 3, 2025 and retroactively effective as of June 30, 2025. The agreement formalizes her previously announced CFO role and sets key compensation terms.
Ms. Russell will receive an annual base salary of $250,000 and be eligible for an annual bonus based on performance and company sales goals agreed with her direct supervisor. She is also granted 200,000 stock options with a strike price of $0.49 per share, which were fully vested as of June 30, 2025, and 350,000 retention RSUs with immediate vesting and a six-month sale hold beginning June 30, 2025. The agreement includes standard non-disclosure provisions and is filed as an exhibit to the report.
Safety Shot, Inc. discloses beneficial ownership and option holdings for its executive officers and directors ahead of the shareholder meeting. The Chief Executive Officer, Jarrett Boon, holds a total of 7,717,000 shares, representing 4.3% of outstanding stock when combining existing and newly reported amounts. The Chairman, John Gulyas, is reported with 7,667,667 shares (4.3%). Other directors and executives show smaller stakes: the Chief Financial Officer, Markita Russell, holds 325,000 shares (0.2%); several directors hold between 600,000 and 750,000 shares each (about 0.4%). These figures appear as aggregated totals of prior holdings plus recently granted or reported amounts and give shareholders a view of insider ownership concentration among the company's leadership.
Lucky Dog Holdings (LDH) disclosed a Schedule 13D reporting its acquisition of Series C Convertible Preferred Stock of Safety Shot, Inc. (SHOT). LDH paid 25,000,000 BONK tokens for 35,000 Series C preferred shares under a Securities Purchase Agreement and acquired an additional 100,000 Series C preferred shares via a Revenue Sharing Agreement tied to 10% of gross revenue of LETSBONK. LDH holds 135,000 Series C shares with stated value $1,000 each; 27,481 are currently convertible into common stock and 107,519 are convertible following stockholder approval. Conversion price is $1.081, and LDH states it would hold the equivalent of 25,422,072 common shares representing 19.99% of the class and acquiring the right to elect 50% of directors upon conversion and consent.
The table lists named executives and directors with their shareholdings and percent ownership in Safety Shot, Inc. (SHOT). Jarrett Boon (CEO) and John Gulyas (Chairman) each hold about 7.7 million shares, representing 4.3% ownership. Other directors and officers hold between 325,000 and 750,000 shares, with reported ownership percentages of about 0.2%–0.4%.
Lucky Dog Holdings (LDH) has disclosed acquiring convertible preferred stock in Safety Shot, Inc. (SHOTW) that could become meaningful common equity. LDH purchased 135,000 shares of Series C Convertible Preferred Stock for digital and revenue-based consideration, of which 27,481 shares are immediately convertible into common stock at $1.081 per share and 107,519 shares are convertible following stockholder approval. The filing reports an aggregate beneficial ownership equal to 25,422,072 common shares on conversion, representing 19.99% of the class.
The agreements include a Securities Purchase Agreement and a Revenue Sharing Agreement under which LDH used $25,000,000 of BONK tokens to acquire preferred shares and received additional preferred shares tied to LETSBONK gross revenue. LDH states the preferred shares give it the right to elect 50% of the issuer's directors and to work with the board to appoint an independent director, subject to stockholder consent.